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Methyl Isocyanate Eight-Day Vapor
Inhalation Study with Fischer 344 Rats
by Darol E. Dodd,* Edward H. Fowler,*
William M. Snellings,* and Irvin M. Pritts*
Groups of ten male and ten female Fischer 344 rats were exposed by inhalation3.1, 0.6, 0.15, or 0.0
(control) ppm of methyl isocyanate (MIC) vapor 6 hr per day for 8 days (two 4-day sessions separated by
a 2-day rest). Evaluation of toxic effects included body weight, food consumption, organ weights, and
selected hematologic, ophthalmic, neurologic, gross anatomic, and histologic examinations. There were
no deaths during the study. Rats of the 3.1 ppm exposure group had decreased body weights, food con-
sumption, and blood oxygen saturation (males only). An increase in hemoglobin concentration (males
only) and in lung weights (absolute and as a percentage ofbody weight) were also observed in the 3.1 ppm
rats. Ophthalmic or neurofunctional behavior evaluations were negative for all MIC exposure groups.
Only 3.1 ppm ofMIC vapor resulted in lesions in the respiratory tract, 0.6 or 0.15 ppm did not. The types
oflesions observed were inflammation and squamous metaplasia in the nasal cavity, trachea, and bronchi;
inflammation ofthe bronchioles and alveoli; and submucosal fibroplasia ofthe bronchioles. No significant
lesions were observed in tissues other than those ofthe respiratory tract in all MIC exposure groups. The
results ofthis study indicate the current 0.02 ppm threshold limit value for MIC is not too high regarding
toxicity.
Introduction
Our previous acute inhalation studies with methyl
isocyanate (MIC) vapordeterminedthe LC50values and
described the type and severity ofrespiratory tract le-
sions observed in Fischer 344 rats, B6C3F1 mice, and
Hartley guinea pigs (1-3). The types of biological re-
sponses observed in these acute studies confirmed the
potent irritancy and suspected tissue reactivity ofMIC
vapor. Furthermore, each species appeared to be asuit-
ablemodelforassessment ofMIC irritancy andtoxicity,
although a few differences were observed in the res-
piratory tract following microscopic evaluation (2,3).
The objective of the present study, initiated in 1980
(prior to the Bhopal tragedy), was to examine the toxic
manifestations in rats following 8-day repeated expo-
sure to MIC vapor. As the 6-hr LC50 value for Fischer
344 rats was 6.1 ppm MIC (1), the target MIC concen-
trations selected for the repeated (8-day) exposure
study were 3.0, 0.6, 0.12, and 0.0 (control) ppm. A sec-
ond repeated exposure study was conducted to describe
more fully the lesions in the rat respiratory tract as a
result ofeither4 or8days ofexposure to MIC at similar
exposure concentrations and to characterize subsequent
development of lesions during a 3-month recovery pe-
riod (4,5).
The current 8-hrthreshold limit value (TLV) forMIC
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of 0.02 ppm (6) was established because of its mucous
membrane irritation and sensitization potential. The
present investigation was performed at MIC concen-
trations ranging from 8 to 150 times the current TLV.
Materials and Methods
Details of the materials, vapor generation methods,
and analytical procedures used in this study have been
described elsewhere (4). Briefly, vapors of MIC-nitro-
gengas were metered from a stainless-steel cylinder(1)
containing liquid MIC into stainless-steel and glass
chambers (4350 L), operated at airflows of 1050 to 3000
L/mintogivethe desiredtargetchamberconcentration.
Chamber air was analyzed for MIC one to three times
an hour with a Hewlett Packard 5710A gas chromato-
graph equipped with a nitrogen-phosphorus detector.
Chamber air samples of 50 ,uL to 5 mL, depending on
the target chamber concentration, were taken with
Pressure Lok syringes. Calibration of the gas chro-
matograph was performed with liquid injections ofMIC
inn-hexanestandard solutionspreparedvolumetrically.
Theminimumdetectionlimitwasapproximately50ppb.
Animal Species, Source, and Husbandry
Male and female Fischer344rats (COBS CDF (F344)/
CrlBR), 33 days of age, were received from Charles
River Breeding Laboratories (Portage, MI). Upon ar-DODD ETAL.
rival, fecal samples were examined for intestinal par-
asites by zinc sulfate flotation. The results were nega-
tive. The animals were kept on a 12-hr light/dark
photoperiod throughout the study. Water, supplied by
an automatic watering system, and powdered NIH-07
feed (Batch #553) supplied by Zeigler Brothers, Inc.
(Gardners, PA) were available ad libitumexceptduring
inhalation exposures. The rats were separated into ex-
posure groups and sex, numbered by toe clipping, and
housed two per cageinstainless-steel, wire-mesh cages.
A layer of Deotized Animal Cage Board (Upjohn Com-
pany, Kalamazoo, MI) was placed under each shelf of
cages except during inhalation exposures. For the in-
halation exposures, rats were transferred from their
home cages to stainless-steel, wire-mesh cages (2 rats/
cage) in the chamber.
Body weight and physical condition of all rats were
followed forapproximately 2weeks priortorandomized
assignment into exposure groups often per sex. At the
time of group assignment, only animals with body
weights within two standard deviations of the group
mean for each sex were used in the study. Any animal
in poor health or having eye lesions was rejected from
group assignments.
Target Concentrations and Exposure
Regimen
Target concentrations of3.0, 0.6, and 0.12 ppm were
selected for this study. Animals (60 days old) were ex-
posed to MIC vapor, 6 hr per day for 4 consecutive
days. After 2 days of nonexposure (weekend period)
animals were exposed for an additional 4 consecutive
days. Control (air-exposed) animals were handled in an
identical manner as MIC-treated animals. To compen-
sate for any possible undetected variation in chamber
exposure conditions (e.g., concentration, temperature,
relative humidity), the position ofrat cages was rotated
within each chamber prior to exposure.
Biological Evaluations
Clinical inspection of the rats was performed daily.
A modified Irwin screen (7) was performed on five rats
per sex of the 3.0, 0.6, and 0.0 ppm groups just prior
to the first MIC exposure and immediately following
the eighth MIC exposure. All rats of the 3.0 and 0.0
ppm groups had a gross ophthalmic examination prior
to initiation of the exposure regimen and just prior to
sacrifice. A light and magnifying lens was used to ob-
serve the cornea and anterior chamber ofthe eye. Body
weights were determined on the morning preceding the
first, second, fourth, and sixth exposure and again im-
mediately prior to sacrifice. Food consumption was
measured for an approximate 15-hrperiod followingthe
third and eighth exposure. Rats were killed by exsan-
guination the morning following the last exposure by
severingthe brachial blood vessels following anesthesia
with methoxyflurane. Rats were subjected to a com-
plete necropsy examination which involved a thorough
externalexaminationfollowedbytheopeningofallbody
cavities, as well as the cranium, and examination ofthe
viscera. The following tissues were placed in 10% neu-
tral buffered formalin (NBF): entire respiratory tract,
bronchial lymph nodes, kidneys, liver, testes, and gross
lesions. The lungs were gentlyinfused and inflated with
10% NBF via the trachea, and the nasal passages were
flushed with 10% NBF before these tissues were placed
infixative. Tissues were examined microscopicallyfrom
all rats ofthe high concentration and control groups. In
addition, the respiratory tracts of rats of the interme-
diate and low concentration groups were examined mi-
croscopically. Thelungs, liver, kidneys, andtesteswere
weighed at the time of sacrifice. Just prior to severing
the brachial blood vessels, blood was obtained from the
orbital sinus of each rat. Blood collection tubes con-
tained EDTA as an anticoagulant. The hematologic as-
sessments were hemoglobin, oxygen saturation, carbon
monoxide saturation, and erythrocyte fragility. An
OSM2 Hemoximeterg spectrophotometer was used to
measure hemoglobin, oxygen saturation, and carbon
monoxide saturation. Sodium dithionite was used to re-
ducethebloodsample (i.e., eliminateoxygen)forcarbon
monoxide determination. For erythrocyte fragility, the
minimum and maximum concentration of phosphate-
buffered saline causing hemolysis was determined.
Statistical Analysis
Results ofthe quantitative continuous variables such
as body weight changes were intercompared amongthe
MIC test groups and the control group using the fol-
lowing tests: Bartlett's homogeneity of variance (8),
analysis of variance (ANOVA), and Duncan's multiple
range (9-11). The latter was used when the F value
from the ANOVA was significant. When Bartlett's test
indicated heterogeneous variances, the F-test (8) was
used to compare each group versus the control. When
these individual F-tests were not significant, Student's
t-test (8) was used; when F-tests were significant, the
means were compared by the Cochran t-test (12). Dis-
continuous data were compared using Fisher's exact
test. A fiducial limit of 0.05 (two-tailed) was used as a
critical level of significance.
Table 1. Chamber concentrations of methyl isocyanate during
the 8-day vapor inhalation study.
Target concentrations, ppm
0.0 0.12 0.6 3.0
Exposure day Daily mean chamber concentrations,a ppm
1 0.0±0.0 0.17±0.02 0.50±0.07 3.8±0.6
2 0.0±0.0 0.19±0.05 0.76±0.21 3.9±0.4
3 0.0±0.0 0.15±0.02 0.63±0.10 2.8±0.4
4 0.0±0.0 0.14±0.05 0.52±0.02 2.6±0.1
5 0.0±0.0 0.17±0.04 0.60±0.05 3.0± 0.2
6 0.0±0.0 0.12±0.01 0.54±0.02 2.9±0.1
7 0.0±0.0 0.11±0.06 0.55±0.03 2.8±0.1
8 0.0±0.0 0.12±0.01 0.52±0.03 2.8±0.1
Mean of
daily means 0.0 ± 0.0 0.15 ± 0.03 0.58 ± 0.09 3.1 ± 0.5
aValues represent mean ± SD.
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Results and Discussion
Chamber Concentrations and
Environmental Conditions
The chamber analytical concentrations ofMIC forthe
8 days of exposure are presented in Table 1. The mean
analytical concentrations were 3.1, 0.6, and 0.15 ppm
for target concentrations of3.0, 0.6, and 0.12 ppm, re-
spectively. The MIC concentration range during each
6-hr exposure was very narrow, as indicated by the
small standard deviation of each daily mean. Nominal
chamberconcentrations werenotcalculated becausethe
concentration ofthe N2-MIC mixture in the head space
of the generation cylinder was not determined. Daily
mean chamber temperature and relative humidity for
all exposure groups ranged from 19.3 to 23.9°C and 50
to 62%, respectively. The housing quarters for the an-
imals were within a temperature range of 19 to 24°C
and had a relative humidity range of46 to 61% through-
out the study period.
Mortality, Clinical Observations,
Ophthalmic Evaluations, and
Neurofunctional Behavior
No animals died during the study. Male and female
rats exposed to 3.1 ppm ofMIC had a higher incidence
of a reddish crust or clear liquid nasal discharge than
air-exposed controls during the exposure regimen.
These rats also appeared unkempt, and audible respi-
ration was noticed, particularly in the males. On the
day of sacrifice, no eye abnormalities were observed in
the 3.1 ppm or control rats.
Results from the Irwin screen indicated no abnormal
behavior in male or female rats of any MIC exposure
group when tested on exposure days 1 and 4. Following
the final exposure day, all five of the male and female
rats ofthe 3.1 ppm group exhibited impaired gaits and
arched backs. No abnormalities were observed in rats
from the 0.6 ppm group. The arched backs were pre-
sumably due to respiratory difficulties, while the ataxia
was attributed to muscular weakness and postural
changes resulting from the large loss in body weight
which occurred in these rats.
Body Weights and Food Consumption
Male and female rats of the 3.1 ppm group lost a
significant amount ofbody weight compared to controls
after the first exposure (Table 2). In both sexes, the
decrease continued with additional MIC exposures.
Both males and females of the 3.1 ppm group gained
some weight during the 2-day nonexposure period, al-
though their body weight changes remained lower than
control values. Male rats exposed to 0.6 ppm MIC had
a significant (p < 0.05) gain in body weight after one
exposure; however, this finding does not appear to be
ofbiological importance. Throughout the remaining ex-
posure regimen, rats ofthe 0.6 or 0.15 ppm groups did
not show differences in body weight gain compared to
controls.
The mean food consumption values for the male and
female rats ofthe 3.1 ppm test group were significantly
lower than the values for the control group following
exposure days 3 and 8 (Table 3). Except for a few iso-
lated instances, no further significant differences were
found in the remaining MIC test groups.
Blood Analysis
Exposure to MIC had no effect on red blood cell fra-
gility. The male rats ofthe 3.1 ppm exposure group had
a statistically significant increase in hemoglobin con-
centration and a decrease in oxygen saturation com-
pared to controls (Fig. 1). No other statistically signif-
icant differences were found among groups of male or
female rats in the remaining hematologic parameters
assessed. These hematologic alterations appear to be
compensatory responses. For example, the decreased
oxygen content of hemoglobin was probably related to
animpairment ofgas exchange function ofthe lung(13).
Mucous plugs were observed microscopically in the
bronchioles of these rats, suggesting heterogeneity of
Table 2. Body weight change for male and female Fischer 344 rats during the methyl isocyanate 8-day vapor inhalation study.
Mean Initial Mean change from initial body weight,a g
chamber body Completed exposure days
concentrations, weight,
Sex ppm ga 1 3 5 8
Male' 3.1 218.64 ± 10.42 -26.53* 3.60 -32.85*+ 4.16 -18.81* 5.92 -40.05* 7.67
0.6 222.03 ± 8.95 3.91t 1.68 8.02 ± 1.32 17.09 ± 1.42 25.50 ± 2.59
0.15 219.21 ± 11.25 1.77 ± 1.15 7.55 ±2.43 16.42 ±2.94 24.25 ± 3.67
0 221.31 ± 9.10 1.83 ± 2.00 8.28 ± 2.21 17.14 ± 2.97 25.77 ± 3.69
Female' 3.1 142.51 ± 7.80 -17.50* 2.29 -17.46*+ 3.66 -5.34 ±4.79 -24.52* 10.87
0.6 145.31 ± 4.09 -1.13 + 3.76 3.93 ± 1.32 13.37 + 1.81 13.29 ± 2.83
0.15 143.63 ± 5.40 0.88 ± 4.00 4.99 ± 3.22 14.40 ± 4.22 13.59 ± 2.81
0 145.44 ± 5.88 -0.54 ±2.50 3.29 ± 3.39 11.94 ± 2.71 12.57 ± 3.19
aValues represent mean ± SD.
bN = 10 rats/group.
*p <0.001 compared to controls.
tp <0.05 compared to controls.
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Table 3. Mean food consumption for male and female Fischer 344 rats during the methyl isocyanate 8-day vapor inhalation study.
Mean food consumption,a Mean glrat/day
chamber
concentrations, Days before exposure Completed exposures
Sex ppm 13 12 3 8
Maleb 3.1 16.52 t 2.55 16.07 t 0.54 7.48t ± 0.68 4.98t t 2.39
0.6 15.39 t 0.72 15.87 t 1.09 19.85 t 5.58 15.34 t 0.26
0.15 16.84* ± 0.91 16.84 t 0.80 19.21 t 0.68 16.01 t 0.72
0 15.19 t 0.58 15.98 t 1.33 19.85 t 1.86 16.10 ± 0.88
Femaleb 3.1 11.59 t 0.73 11.28 t 0.72 6.22t t 0.84 4.72t ± 2.18
0.6 11.69 t 0.92 11.16 ± 0.34 13.63 t 0.59 12.48 t 0.70
0.15 11.93 t 0.63 10.82* ± 0.33 13.03 t 1.15 11.59 t 0.72
0 12.46 t 1.01 11.94 t 0.73 13.31 t 0.93 11.84 ± 0.75
aValues represent mean t SD.
bN = 10 rats/group.
*p <0.01 compared to controls.
tp <0.001 compared to controls.
Table 4. Microscopic findings in the respiratory tract of Fischer 344 rats at the conclusion of the methyl isocyanate 8-day study
MIC concentration, ppm
3.1 0.6 0.15 0.0
Organs/lesions Males Females Males Females Males Females Males Females
Nasal passages
Number of rats examined 10 10 10 10 10 10 10 10
Rhinitis 9* 10* 1 2 0 2 1 1
Epithelial degeneration/necrosis 4 0 0 0 0 0 0 0
Squamous metaplasia 10* 10* 0 0 0 0 0 0
Trachea
Number of rats examined 10 10 10 10 10 10 10 10
Tracheitis 9* 6* 0 0 0 0 0 0
Ulceration 1 0 0 0 0 0 0 0
Squamous metaplasia 10* 9* 0 0 0 0 0 0
Regenerative hyperplasia 1 1 0 0 0 0 0 0
Lungs/bronchioles
Number of rats examined 10 10 10 10 10 10 10 10
Bronchiolitis 10* 9* 0 0 0 0 0 0
Pneumonitis 5* 7* 0 0 0 0 0 0
Squamous metaplasia 4 9* 0 0 0 0 0 0
Regenerative hyperplasia 0 1 0 0 0 0 0 0
Intraluminal and submucosal fibroplasia 4 0 0 0 0 0 0 0
Bronchial lymph nodes
Number ofrats examined 8 7 5 9 7 7 7 6
Reactive hyperplasia 5* 5* 0 0 0 0 0 0
*p <0.05 compared to controls.
lung ventilation. Thus, a decrease in blood oxygen con-
tent may explain the decrease in oxygen content of
hemoglobin, and the increase in hemoglobin concentra-
tion may have resulted from a diminished hemoglobin
oxygen saturation. Determination of hematologic pa-
rameters in the present study was a result of a sus-
pected interaction between MIC and hemoglobin. Car-
bamylation of either sodium or potassium isocyanate
with hemoglobin has been reported (14,15). Further-
more, Lee (16) observed a carbamylation reaction in
vitro between liquid MIC and hemoglobin S from sickle
cell patients. Subsequent to this study, experiments
were performed to determine the influence of MIC on
oxygen-binding properties ofguinea pig blood (17). Al-
though no data are available regarding the metabolism
of MIC, the absence ofcarbon monoxide saturation in-
dicates, indirectly, that MIC is not largely metabolized
to carbon monoxide in vivo.
Organ Weights
Absolute lung weights increased 28 and 49% over
control animal values for the 3.1 ppm male and female
rats, respectively (Fig. 2). Relativelungweights (aper-
centage of body weight) of the 3.1 ppm rats were also
significantly increased from the control mean values.
The mean absolute weights of the liver, kidneys, and
testes were decreased in rats ofthe 3.1 ppm group, but
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FIGURE 1. Hemoglobin and oxygen saturation results for male and female Fischer 344 rats at the conclusion of the 8-day methyl isocyanate
exposure regimen. Group size was N = 10 for both sexes. The mean and SD are depicted by each bar.
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FIGURE 2. Absolute lung weights for male and female Fischer 344 rats at the conclusion of the 8-day methyl isocyanate exposure regimen.
Group size was N = 10 for both sexes. The mean and SD are depicted by each bar.
in the absence of gross and microscopic lesions, these
alterations were considered to be a reflection of the
significant body weight losses which occurred in these
animals. For rats ofthe 0.6 and 0.15 ppm groups, there
were no differences in mean absolute organ weights
when compared to respective control animal values.
Histopathology
Gross lesions ofbiological significance were confined
to the lungs ofmale and female rats exposed to 3.1 ppm
of MIC vapor and consisted of reddening of the lungs
(pulmonary congestion) that was distributed over the
surface in either apatchy (mostfrequent), focal, orgen-
eralized fashion. Microscopic findings of biological sig-
nificance were also confined to the respiratory tract of
the 3.1 ppm-exposed male and female rats, and con-
sisted of inflammation, epithelial degeneration, squa-
mous metaplasia, and regenerative hyperplasia extend-
ing down to and including the respiratory bronchioles.
Table 4 presents the distribution oflesions found in the
respiratory tract. Rhinitis was present in both sexes,
with slightly more severe rhinitis occurring in the
males. Rhinitis was moderate or marked in most in-
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FIGURE 3. Chronic rhinitis with purulent exudate in the anterior
nasal cavity ofa male rat exposed to 3.1 ppm ofmethyl isocyanate
vapor for 8 days. H & E, x 250. (Reprinted courtesy ofAcademic
Press.)
FIGURE 4. Squamous metaplasia ofturbinate mucosa in the anterior
nasal passage ofamaleratexposed to3.1 ppmofmethylisocyanate
vapor for 8 days. H & E, x 250. (Reprinted courtesy ofAcademic
Press.)
stances (Fig. 3). Squamous metaplasia of moderate or
marked severity was seen in both sexes in the respi-
ratory mucosa ofthe nasal cavity (Fig. 4) and extended
throughout the respiratory tract down into the bron-
chioles (Fig. 5). Epithelial celldegeneration was present
inboth therespiratory and olfactory mucosaofthenasal
cavity in the males.
A biologically important lesion found primarily in the
lungs of male rats exposed to 3.1 ppm was submucosal
fibroplasia. These lesions developed in the walls of the
bronchioles and projected into the lumina ofthe airways
as polyps. These polypoid projections were covered by
regenerative epithelium and contained cores of imma-
ture connective tissues (Fig. 6). Some of the lesions
were quite large, although there was no microscopic
evidence that they obstructed the airway. It is believed
that these focal or multifocal areas ofsubmucosal fibro-
FIGURE 5. Squamous metaplasia of the bronchiolar epithelium of a
male rat exposed to 3.1 ppmofmethylisocyanate vaporfor8days.
H & E, x 250. (Reprinted courtesy of Academic Press.)
FIGURE 6. Immature submucosal fibroplasia covered by regenera-
tive epithelium in an intraluminal polyp extending from the bron-
chiolar wall in a male rat exposed to 3.1 ppm ofmethyl isocyanate
vapor for 8 days. H & E, x 250. (Reprinted courtesy ofAcademic
Press.)
plasia were in response to ulceration of overlying epi-
thelium following necrosis induced by the MIC vapor.
Similar lesions have been reported in rats exposed to
toluene diisocyanate (TDI) and were termed bronchiol-
itis fibrosa obliterans (18,19).
Reactive hyperplasia of the bronchial lymph nodes
was present in both the male and female rats ofthe 3.1
ppm exposure group. Bronchiolitis was present in both
male and female rats exposed to 3.1 ppm ofMIC vapor,
but was more severe in male rats. Mucous plugs con-
taining inflammatory cells were seen frequently in the
bronchioles of both sexes and were believed to have
originated farther up in the respiratory passages and
to have been inspired to the point of lodgement (Fig.
7).
To describe more fully the lesions in the rat respi-
ratory tract as a result ofeither 4 or 8 days ofexposure
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FIGURE 7. Inspired mucus and inflammatory cells in the terminal
bronchiole, alveolar duct, and alveoli of a male rat exposed to 3.1
ppm of methyl isocyanate vapor for 8 days. H & E, x 160. (Re-
printed courtesy of Academic Press.)
to 3 ppm of MIC and to characterize the subsequent
development ofthese lesions during a 3-month recovery
period, an additional repeated exposure study was per-
formed (4,5). Recovery from the necrotizing and irri-
tating effects of MIC vapor was observed.
Conclusion
Previous inhalation studies with MIC examined the
biological responses which occurred following a single
4- or6-hr exposure (1,2,3,20). The present study focused
on the biological responses which resulted from re-
peated exposures of MIC. As expected from the acute
studies, signs of irritancy on the mucosal surfaces of
the eyes, nose, and mouth were observed following re-
peated exposure of 3.1 ppm, and the location of MIC-
induced morphologic alterations was restricted to the
respiratory tract. In human volunteer studies, irritation
ofthe eyes, nose, and throat were perceived at 0.5 ppm
of MIC vapor for short durations (21). A concentration
of 0.4 ppm (20) or 0.3 ppm (22) produced no irritation.
The current TLV for MIC is 0.02 ppm (6) due to mucous
membrane irritation and sensitization potential. The re-
sults of the present investigation indicate the current
TLV is not too high regarding toxicity, since no adverse
effects were observed in rats from repeated exposure
of concentrations approximately 30 times greater than
0.02 ppm. Other investigators working with laboratory
animal models to quantitate the stresses of sensory and
pulmonary irritation agree with the current TLV for
MIC (23).
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